DE602005027258D1 - Humane monoklonale antikörper gegen hendra- und nipah-viren - Google Patents
Humane monoklonale antikörper gegen hendra- und nipah-virenInfo
- Publication number
- DE602005027258D1 DE602005027258D1 DE602005027258T DE602005027258T DE602005027258D1 DE 602005027258 D1 DE602005027258 D1 DE 602005027258D1 DE 602005027258 T DE602005027258 T DE 602005027258T DE 602005027258 T DE602005027258 T DE 602005027258T DE 602005027258 D1 DE602005027258 D1 DE 602005027258D1
- Authority
- DE
- Germany
- Prior art keywords
- antibodies
- hendra
- monoclonal antibodies
- nipah virus
- human monoclonal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000700605 Viruses Species 0.000 title 1
- 241000893570 Hendra henipavirus Species 0.000 abstract 3
- 241000526636 Nipah henipavirus Species 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1009—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/115—Paramyxoviridae, e.g. parainfluenza virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66176605P | 2005-03-14 | 2005-03-14 | |
US67854705P | 2005-05-05 | 2005-05-05 | |
US71890205P | 2005-09-20 | 2005-09-20 | |
PCT/US2005/040050 WO2006137931A2 (en) | 2005-03-14 | 2005-11-04 | Human monoclonal antibodies against hendra and nipah viruses |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005027258D1 true DE602005027258D1 (de) | 2011-05-12 |
Family
ID=37570906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005027258T Active DE602005027258D1 (de) | 2005-03-14 | 2005-11-04 | Humane monoklonale antikörper gegen hendra- und nipah-viren |
Country Status (7)
Country | Link |
---|---|
US (5) | US7988971B2 (de) |
EP (2) | EP2336174B8 (de) |
AT (1) | ATE503770T1 (de) |
AU (1) | AU2005333155B2 (de) |
DE (1) | DE602005027258D1 (de) |
ES (1) | ES2546543T3 (de) |
WO (1) | WO2006137931A2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR045563A1 (es) | 2003-09-10 | 2005-11-02 | Warner Lambert Co | Anticuerpos dirigidos a m-csf |
ES2673972T3 (es) * | 2004-07-09 | 2018-06-26 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Formas solubles de la glicoproteína G de los virus hendra y nipah |
ES2546543T3 (es) | 2005-03-14 | 2015-09-24 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Anticuerpos monoclonales humanos contra los virus Hendra y Nipah |
US7858752B2 (en) * | 2006-12-05 | 2010-12-28 | Abbott Laboratories | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same |
GB0700133D0 (en) | 2007-01-04 | 2007-02-14 | Humabs Llc | Human cytomegalovirus neutralising antibodies and use thereof |
US7947274B2 (en) | 2007-01-04 | 2011-05-24 | Humabs, LLC. | Human cytomegalovirus neutralising antibodies and use thereof |
PT2178921E (pt) | 2007-07-17 | 2016-03-23 | Squibb & Sons Llc | Anticorpos monoclonais contra glipicano-3 |
KR20150002895A (ko) * | 2008-07-16 | 2015-01-07 | 인스티튜트 포 리서치 인 바이오메드슨 | 인간 사이토메갈바이러스 중화 항체 및 이의 용도 |
ES2654543T3 (es) | 2008-07-16 | 2018-02-14 | Institute For Research In Biomedicine | Anticuerpos neutralizantes del citomegalovirus humano y uso de los mismos |
AU2011282423B2 (en) | 2010-07-22 | 2015-05-14 | Schrader, Sabariah | Cross-protective pathogen protection, methods and compositions thereof |
CA3037903A1 (en) * | 2010-10-09 | 2012-04-26 | Mayo Foundation For Medical Education & Research | Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease |
WO2012149536A1 (en) * | 2011-04-28 | 2012-11-01 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Neutralizing antibodies to nipah and hendra virus |
MX352604B (es) | 2011-05-13 | 2017-11-30 | Zoetis Llc | Composiciones inmunogenicas de la glucoproteina g de los virus hendra y nipah. |
ES2735289T3 (es) * | 2012-02-08 | 2019-12-17 | Igm Biosciences Inc | Proteínas de unión a cdim y usos de las mismas |
RU2660566C2 (ru) * | 2012-10-01 | 2018-07-06 | Томас Джефферсон Юниверсити | Иммунизация вектором на основе вируса бешенства, экспрессирующим чужеродный белковый антиген |
WO2014105849A1 (en) * | 2012-12-28 | 2014-07-03 | Xoma (Us) Llc | Antibodies specific for fgfr4 and methods of use |
DK2968520T3 (da) | 2013-03-14 | 2021-08-09 | Macrogenics Inc | Bispecifikke molekyler som er immunoreaktive med immuneffektorceller der udtrykker en aktiverende receptor |
KR20160077214A (ko) | 2013-12-16 | 2016-07-01 | 조에티스 서비시즈 엘엘씨 | 헨드라 및 니파 바이러스 g 당단백질 면역원성 조성물 |
WO2015112836A2 (en) * | 2014-01-24 | 2015-07-30 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Antibodies against f glycoprotein of hendra and nipah viruses |
WO2016054101A1 (en) | 2014-09-29 | 2016-04-07 | Duke University | Bispecific molecules comprising an hiv-1 envelope targeting arm |
WO2016090365A1 (en) * | 2014-12-05 | 2016-06-09 | Dessain Scott Kendall | Pdk1 binding molecules and uses thereof |
US20190183997A1 (en) * | 2016-07-22 | 2019-06-20 | University Of Washington | Identification and production of high affinity igm antibodies and derivatives thereof |
JP7370983B2 (ja) | 2017-12-20 | 2023-10-30 | ゾエティス・サービシーズ・エルエルシー | ヘンドラウイルス感染症及びニパウイルス感染症に対するワクチン |
WO2019143884A1 (en) * | 2018-01-19 | 2019-07-25 | Vanderbilt University | Conserved hiv antibody clonotypes and methods of use |
CN110028579B (zh) * | 2019-05-05 | 2020-12-18 | 中国人民解放军军事科学院军事医学研究院 | 一种抗尼帕病毒包膜糖蛋白的单克隆抗体及其应用 |
KR102264873B1 (ko) | 2020-01-17 | 2021-06-14 | 대한민국(질병관리청장) | 니파바이러스 g 당단백질에 특이적인 단클론 항체 및 이의 용도 |
WO2021257894A1 (en) * | 2020-06-19 | 2021-12-23 | Board Of Regents, The University Of Texas System | Anti-bst2 antibodies targeting bst2 long isoform |
CN113968907B (zh) * | 2020-07-22 | 2023-05-26 | 中国人民解放军军事科学院军事医学研究院 | 具有中和活性的抗尼帕病毒单克隆抗体及应用 |
CN113968908B (zh) * | 2020-07-22 | 2023-03-14 | 中国人民解放军军事科学院军事医学研究院 | 具有广谱中和活性的抗亨尼帕病毒单克隆抗体及应用 |
WO2022177913A1 (en) * | 2021-02-16 | 2022-08-25 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Molecules that bind to mesothelin polypeptides |
WO2023109844A1 (en) * | 2021-12-14 | 2023-06-22 | Doma Biopharmaceutical (Suzhou) Co., Ltd. | Antibodies and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US661766A (en) | 1899-11-07 | 1900-11-13 | Carl J Mellin | Piston-valve. |
US678547A (en) | 1901-05-31 | 1901-07-16 | Seth S Crocker | Fountain-pen. |
GB9221654D0 (en) * | 1992-10-15 | 1992-11-25 | Scotgen Ltd | Recombinant human anti-cytomegalovirus antibodies |
US7666431B2 (en) | 2001-11-13 | 2010-02-23 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Compositions and methods for the inhibition of membrane fusion by paramyxoviruses |
WO2005028673A1 (en) * | 2003-09-22 | 2005-03-31 | Institut Pasteur | A method for detecting nipah virus and method for providing immunoprotection against henipaviruses |
ES2546543T3 (es) * | 2005-03-14 | 2015-09-24 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Anticuerpos monoclonales humanos contra los virus Hendra y Nipah |
-
2005
- 2005-11-04 ES ES10180621.4T patent/ES2546543T3/es active Active
- 2005-11-04 WO PCT/US2005/040050 patent/WO2006137931A2/en active Application Filing
- 2005-11-04 DE DE602005027258T patent/DE602005027258D1/de active Active
- 2005-11-04 AU AU2005333155A patent/AU2005333155B2/en active Active
- 2005-11-04 EP EP10180621.4A patent/EP2336174B8/de active Active
- 2005-11-04 US US11/886,307 patent/US7988971B2/en active Active
- 2005-11-04 AT AT05858301T patent/ATE503770T1/de not_active IP Right Cessation
- 2005-11-04 EP EP05858301A patent/EP1861424B1/de active Active
-
2011
- 2011-08-01 US US13/195,366 patent/US8313746B2/en active Active
-
2012
- 2012-11-08 US US13/671,721 patent/US20130149246A1/en not_active Abandoned
-
2013
- 2013-09-13 US US14/026,142 patent/US8858938B2/en active Active
-
2014
- 2014-09-18 US US14/490,328 patent/US20150071854A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2336174A2 (de) | 2011-06-22 |
US8858938B2 (en) | 2014-10-14 |
AU2005333155B2 (en) | 2011-11-17 |
US20140079715A1 (en) | 2014-03-20 |
ATE503770T1 (de) | 2011-04-15 |
AU2005333155A1 (en) | 2006-12-28 |
ES2546543T3 (es) | 2015-09-24 |
US20120064000A1 (en) | 2012-03-15 |
EP2336174B1 (de) | 2015-06-03 |
WO2006137931A3 (en) | 2007-04-26 |
EP2336174A3 (de) | 2012-07-04 |
US20090214428A1 (en) | 2009-08-27 |
US20150071854A1 (en) | 2015-03-12 |
US8313746B2 (en) | 2012-11-20 |
EP2336174B8 (de) | 2015-09-23 |
WO2006137931A2 (en) | 2006-12-28 |
EP1861424A2 (de) | 2007-12-05 |
US20130149246A1 (en) | 2013-06-13 |
EP1861424B1 (de) | 2011-03-30 |
US7988971B2 (en) | 2011-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005027258D1 (de) | Humane monoklonale antikörper gegen hendra- und nipah-viren | |
WO2005056600A3 (en) | Monoclonal antibodies that bind or neutralize dengue virus | |
EA202091710A1 (ru) | Антитела против cd73 и способы их применения | |
NO20082559L (no) | Humane monoklonale antistoffer mot protein tyrosin kinase 7 (PTK7) og fremgangsmater for anvendelse av anti-PTK7 antistoffer | |
NO20092285L (no) | Humane, monoklonale antistoffer til BTLA og fremgangsmater for anvendelse | |
NO20085362L (no) | Hoyaffinitets humane og humaniserte anti-alfa5 beta1-integrin funksjonsblokkerende antistoffer med redusert immunogenisitet | |
CY1121637T1 (el) | Αντι-dkk-1 αντισωματα | |
CY1118977T1 (el) | Επιτοποι σκληροστινης | |
EA201170357A1 (ru) | Инженерные антитела к il-13: композиции, способы и применение | |
EA201000424A1 (ru) | Антитела к il-23 | |
NO20081987L (no) | Humane, monoklonale antistoffer mot CD70 | |
NO20091387L (no) | Antistoffer mot benmorfogene proteiner og reseptorer derav, fremgangsmater for deres anvendelse | |
CO6630164A2 (es) | Proteinas que se unen al tnf-a | |
NO20083062L (no) | Humane monoklonale antistoffer mot fukosyl-GM1 og fremgangsmater for anvendelse av anti-fukosyl-GM1 | |
EA201790330A1 (ru) | Белки, связывающиеся с bcma (cd269/tnfrsf17) | |
EA201170205A1 (ru) | Антитела, нейтрализующие цитомегаловирус человека, и их применение | |
UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
EA201200217A1 (ru) | Рнк с комбинацией из немодифицированных и модифицированных нуклеотидов для экспрессии белков | |
BR112012003064B8 (pt) | anticorpo ou fragmento de ligação de antígeno do mesmo, combinação que os compreende, método de detecção de infecção por rsv, moléculas de ácido nucléico, e método de produção de um anticorpo ou fragmento de ligação de antígeno do mesmo | |
EA200800355A1 (ru) | Нейтрализующие антитела человека против b7rp1 | |
UA100682C2 (ru) | АНТИТЕЛО, КОТОРОЕ НЕЙТРАЛИЗУЕТ ЧЕЛОВЕЧЕСКИЙ ЦИТОМЕГАЛОВИРУС (hCMV), И ЕГО ПРИМЕНЕНИЕ | |
BRPI0818437A2 (pt) | Anticorpo ou fragmento funcional do anticorpo, composição farmacêutica, uso de pelo menosum dos anticorpos ou fragmentos funcionais dos anticorpos, e, hibridoma | |
BRPI0606790A2 (pt) | anticorpo humano isolado ou porção de ligação de antìgeno do mesmo, polipeptìdeo isolado, composição, ácido nucleico isolado, vetor de expressão célula hospedeira, vacina contra a raiva, kit, uso de um anticorpo monoclonal humano isolado ou porção de ligação de antìgeno do mesmo, ou de uma quantidade eficaz de uma composição, método para identificar um anticorpo ou um fragmento do mesmo, anticorpo ou fragmento do mesmo, anticorpo ou fragmento do mesmo,e, glicoproteìna. | |
ATE503769T1 (de) | Antikörper gegen das humane cytomegalie-virus (hcmv) | |
AU2012249274A8 (en) | Neutralizing antibodies to Nipah and Hendra virus |